共 50 条
Clinical, sonographic, and molecular changes in calcific tendinitis of the shoulder following extracorporeal shockwave therapy: a prospective case-control study
被引:0
|作者:
Chou, Wen-Yi
[1
,2
,3
,4
]
Wu, Kuan-Ting
[1
,2
,3
]
Chen, Po-Cheng
[5
]
Jhan, Shun-Wun
[1
,2
,3
]
Wu, Chia-Feng
[1
,2
,3
]
Cheng, Jai-Hong
[3
,4
,6
]
机构:
[1] Kaohsiung Chang Gung Mem Hosp, Dept Orthopaed Surg, Kaohsiung, Taiwan
[2] Chang Gung Univ, Coll Med, Kaohsiung, Taiwan
[3] Kaohsiung Chang Gung Mem Hosp, Ctr Shockwave Med & Tissue Engn, Kaohsiung 83301, Taiwan
[4] Cheng Shiu Univ, Dept Leisure & Sport Management, Kaohsiung, Taiwan
[5] Kaohsiung Chang Gung Mem Hosp, Dept Phys Med & Rehabil, Kaohsiung, Taiwan
[6] Kaohsiung Chang Gung Mem Hosp, Dept Med Res, Kaohsiung, Taiwan
关键词:
angiogenesis;
BMP7;
calcified shoulder;
growth factor;
shockwave;
WAVE THERAPY;
ROTATOR CUFF;
D O I:
10.1097/JS9.0000000000002078
中图分类号:
R61 [外科手术学];
学科分类号:
摘要:
Background:Extracorporeal shockwave therapy (ESWT) is the primary treatment for calcific tendinitis of the shoulders, but what are the effects of clinical, sonographic, and molecular markers following ESWT in treating calcific tendinitis of the shoulder?Methods:Twenty-eight patients were categorized into radiodense and radiolucent subgroups. In addition, clinical assessments included the visual analogue scale (VAS), Constant-Murley (CM) score, American Shoulder and Elbow Surgeon (ASES) score, sonographic evaluation, and serum enzyme-linked immunosorbent assay (ELISA). The participants completed a 1-year follow-up. All data were collected before and after treatment.Results:After 1 year of follow-up, all patients showed notable improvement in VAS, CM, and ASES scores, with no significant clinical variations among the subgroups. However, the radiolucent group showed significant complete resorption and size reduction at the final follow-up. The sonographic evaluation revealed improved tissue perfusion and reduced calcification from 3 to 12 months in all patients, including those in the radiolucent group, but complete resorption of calcific deposits did not occur. The percentage of tissue perfusion was improved at 1 and 3 months after ESWT. There were no significant differences in the levels of the molecular markers interleukin-1 beta (IL-1 beta) or IL-33, but the level of insulin-like growth factor 1 (IGF-1) was notably increased at 1 and 3 months post-ESWT. The BMP7 level was increased at 3 months and was then decreased significantly at 6 and 12 months.Conclusion:ESWT improved symptoms, reduced calcification, enhanced tissue perfusion, and promoted angiogenesis and BMP7 activity. In particular, it benefited radiolucent type patients with better calcification resorption. Partial resorption led to improvements in transparency, and a second ESWT session at 3 months was recommended for optimal results.
引用
收藏
页码:7447 / 7455
页数:9
相关论文